Dr. Sidhu joins Treadwell with 15 years of experience in hematologic and solid tumor oncology research and development, according to a Feb. 3 release. He most recently served as chief medical officer of Brooklyn ImmunoTherapeutics, now known as Eterna.
Dr. Sidhu previously served as president and chief medical officer of Roivant Sciences, chief medical officer of Cell Design Labs and executive medical director of hematology/oncology therapeutics for Amgen.
He is also a fellow of the Royal College of Physicians and Surgeons of Canada, where he received his medical training.
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.